scholarly journals The Role of Peripheral Nerve Function in Age-Related Bone Loss and Changes in Bone Adaptation

2014 ◽  
Author(s):  
Blaine A. Christiansen
Author(s):  
Christina M. A. P. Schuh ◽  
Ana Maria Sandoval-Castellanos ◽  
Cristian De Gregorio ◽  
Pamina Contreras-Kallens ◽  
John W. Haycock

2020 ◽  
pp. 215-236
Author(s):  
Christina M. A. P. Schuh ◽  
Ana Maria Sandoval-Castellanos ◽  
Cristian De Gregorio ◽  
Pamina Contreras-Kallens ◽  
John W. Haycock

2003 ◽  
Vol 60 (6) ◽  
pp. 1209-1216 ◽  
Author(s):  
D. Ceballos ◽  
N. Lago ◽  
E. Verdú ◽  
M. Penkowa ◽  
J. Carrasco ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Jana Müller ◽  
Charlotte Kreutz ◽  
Steffen Ringhof ◽  
Maximilian Koeppel ◽  
Nikolaus Kleindienst ◽  
...  

AbstractImpaired postural control is often observed in response to neurotoxic chemotherapy. However, potential explanatory factors other than chemotherapy-induced peripheral neuropathy (CIPN) have not been adequately considered to date due to primarily cross-sectional study designs. Our objective was to comprehensively analyze postural control during and after neurotoxic chemotherapy, and to identify potential CIPN-independent predictors for its impairment. Postural control and CIPN symptoms (EORTC QLQ-CIPN20) were longitudinally assessed before, during and three weeks after neurotoxic chemotherapy, and in three and six months follow-up examinations (N = 54). The influence of peripheral nerve function as determined by nerve conduction studies (NCS: compound motor action potentials (CMAP) and sensory action potentials (SNAP)), physical activity, and muscle strength on the change in postural control during and after chemotherapy was analyzed by multiple linear regression adjusted for age and body mass index. Postural control, CIPN signs/symptoms, and CMAP/SNAP amplitudes significantly deteriorated during chemotherapy (p < .01). During follow-up, patients recovered from postural instabilities (p < .01), whereas CIPN signs/symptoms and pathologic NCS findings persisted compared to baseline (p < .001). The regression model showed that low CMAP and high SNAP amplitudes at baseline predicted impairment of postural control during but not after chemotherapy. Hence, pre-therapeutically disturbed somatosensory inputs may induce adaptive processes that have compensatory effects and allow recovery of postural control while CIPN signs/symptoms and pathologic peripheral nerve function persist. Baseline NCS findings in cancer patients who receive neurotoxic chemotherapy thus might assist in delineating individual CIPN risk profiles more precisely to which specific exercise intervention programs could be tailor-made.


Nutrients ◽  
2021 ◽  
Vol 13 (4) ◽  
pp. 1222
Author(s):  
Domitilla Mandatori ◽  
Letizia Pelusi ◽  
Valeria Schiavone ◽  
Caterina Pipino ◽  
Natalia Di Pietro ◽  
...  

Osteoporosis (OP) and vascular calcification (VC) represent relevant health problems that frequently coexist in the elderly population. Traditionally, they have been considered independent processes, and mainly age-related. However, an increasing number of studies have reported their possible direct correlation, commonly defined as “bone-vascular crosstalk”. Vitamin K2 (VitK2), a family of several natural isoforms also known as menaquinones (MK), has recently received particular attention for its role in maintaining calcium homeostasis. In particular, VitK2 deficiency seems to be responsible of the so-called “calcium paradox” phenomenon, characterized by low calcium deposition in the bone and its accumulation in the vessel wall. Since these events may have important clinical consequences, and the role of VitK2 in bone-vascular crosstalk has only partially been explained, this review focuses on its effects on the bone and vascular system by providing a more recent literature update. Overall, the findings reported here propose the VitK2 family as natural bioactive molecules that could be able to play an important role in the prevention of bone loss and vascular calcification, thus encouraging further in-depth studies to achieve its use as a dietary food supplement.


Amyloid ◽  
2003 ◽  
Vol 10 (1) ◽  
pp. 17-24 ◽  
Author(s):  
Sachio Kobayashi ◽  
Hiroshi Morita ◽  
Teruko Asawa ◽  
Yo-Ichi Takei ◽  
Takao Hashimoto ◽  
...  

1990 ◽  
Vol 11 (4) ◽  
pp. 451-456 ◽  
Author(s):  
C VANDERZEE ◽  
T SCHUURMAN ◽  
R VANDERHOOP ◽  
J TRABER ◽  
W GISPEN

Sign in / Sign up

Export Citation Format

Share Document